PHENOTYPIC ANTIBIOTIC RESISTANCE PROFILES OF GRAM-NEGATIVE BACTERIA IN CLINICAL SAMPLES PRE AND DURING COVID-19 PANDEMIC AT ZONAL REFERRAL HOSPITAL NORTHERN TANZANIA
DOI:
https://doi.org/10.21010/Ajidv19i2S.1%20Keywords:
Antibiotic resistance, COVID-19, Gram- negative bacteriaAbstract
Background: COVID-19 has aggravated antimicrobial use owing to limited treatment options, raising concerns about antimicrobial resistance, which was previously estimated to potentially cause 10 million global deaths within 30 years. This study evaluated the potential impact of the COVID-19 pandemic on antibiotic resistance in referral hospitals.
Material and Methods: A cross-sectional study at Kilimanjaro Christian Medical Centre analyzed clinical bacterial samples from pre-COVID-19 (2018) and during COVID-19 (2020, 2023). Two hundred isolates from 2018 and 2020, and 121 samples from 2023, were examined. Bacterial isolates were identified using API 20E for Enterobacteriaceae (bioMérieux) and standard biochemical tests, while antimicrobial susceptibility was assessed using the disc diffusion method.
Results: During the COVID-19 pandemic, antibiotic resistance among bacteria has increased significantly. Resistance to ampicillin 113 (95.8%, p=0.018), ceftriaxone 102 (74.5%, p=0.043), and ciprofloxacin 119 (68.8%, p=0.003) increased. Conversely, resistance to chloramphenicol 19 (16.1%, p=0.021) and amoxicillin-clavulanic acid decreased to 62 (52.5 %, p = 0.007). Klebsiella pneumoniae showed decreased resistance to chloramphenicol 11(20.8%, p=0.004) and amoxicillin-clavulanic acid 27(50.9%, p=0.034). Acinetobacter species also showed a significant increase in ceftriaxone resistance 18(94.7%, p=0.018). Among the 233 isolates, ESBL-producing bacteria were identified in 101 (43.4%), and Klebsiella pneumoniae and Escherichia coli showed the highest frequencies at 40 (39.6%) and 54 (53.5%), respectively.
Conclusion: During COVID-19, ampicillin, ciprofloxacin, and ceftriaxone resistance significantly increased, whereas restricted antibiotics, such as meropenem, showed lower resistance. The extensive and uncontrolled use of antibiotics during the pandemic has aggravated antimicrobial resistance, necessitating intensified and coordinated efforts to combat it.
References
Abdelaziz Abdelmoneim, Shaimaa, Ramy Mohamed Ghazy, Eman Anwar Sultan, Mahmoud A. Hassaan, and Mohamed Anwar Mahgoub. (2024). “Antimicrobial Resistance Burden Pre and Post-COVID-19 Pandemic with Mapping the Multidrug Resistance in Egypt: A Comparative Cross-Sectional Study.” Scientific Reports 14 (1): 1–13. https://doi.org/10.1038/s41598-024-56254-4.
Abubakar, Usman, Ahmed Awaisu, Amer Hayat Khan, and Khurshid Alam. (2023). “Impact of COVID-19 Pandemic on Healthcare-Associated Infections: A Systematic Review and Meta-Analysis.” Antibiotics (Basel, Switzerland) 12 (11). https://doi.org/10.3390/antibiotics12111600.
Aila, Nabil Abdullah El, Nahed Ali Al Laham, and Basim Mohammed Ayesh. (2023). “Prevalence of Extended Spectrum Beta Lactamase and Molecular Detection of BlaTEM, BlaSHV and BlaCTX-M Genotypes among Gram Negative Bacilli Isolates from Pediatric Patient Population in Gaza Strip.” BMC Infectious Diseases 23 (1): 99. https://doi.org/10.1186/s12879-023-08017-1.
Aldhwaihi, Khaled Abdulrahman, Saud M. Alsanad, Abdulrahman Hadi Almutiri, and Saad Aldoihi. (2021). “Assessment of Antibiotic Resistance Pattern of Bacteria Prevalent during COVID-19 Pandemic.” Journal of Pharmaceutical Research International, 117–27. https://doi.org/10.9734/jpri/2021/v33i57a33975.
Ansari, Shamshul, John P. Hays, Andrew Kemp, Raymond Okechukwu, Jayaseelan Murugaiyan, Mutshiene Deogratias Ekwanzala, Maria Josefina Ruiz Alvarez, (2021). “The Potential Impact of the COVID-19 Pandemic on Global Antimicrobial and Biocide Resistance: An AMR Insights Global Perspective.” JAC-Antimicrobial Resistance 3 (2): 1–12. https://doi.org/10.1093/jacamr/dlab038.
Bizri, Abdul Rahman, Alia Abd El-Fattah, Hafez Mahmoud Bazaraa, Jamal Wadi Al Ramahi, Madonna Matar, Rana Abdulmahdi Nahi Ali, Rowan El Masry, Jihane Moussa, Ali Jamal Al Abbas, and Mohamed Abdel Aziz. (2023). “Antimicrobial Resistance Landscape and COVID-19 Impact in Egypt, Iraq, Jordan, and Lebanon: A Survey-Based Study and Expert Opinion.” PLoS ONE 18 (7 July): 1–22. https://doi.org/10.1371/journal.pone.0288550.
Chinemerem Nwobodo, David, Malachy Chigozie Ugwu, Clement Oliseloke Anie, Mushtak T.S. Al-Ouqaili, Joseph Chinedu Ikem, Uchenna Victor Chigozie, and Morteza Saki. (2022). “Antibiotic Resistance: The Challenges and Some Emerging Strategies for Tackling a Global Menace.” Journal of Clinical Laboratory Analysis 36 (9): 1–10. https://doi.org/10.1002/jcla.24655.
CLSI. (2021). “M100: Performance Standards for Antimicrobial Susceptability Testing: Clinical & Laboratory Standards Institute; 2021.”
Despotovic, Aleksa, Branko Milosevic, Andja Cirkovic, Ankica Vujovic, Ksenija Cucanic, Teodora Cucanic, and Goran Stevanovic. (2021). “The Impact of Covid-19 on the Profile of Hospital-Acquired Infections in Adult Intensive Care Units.” Antibiotics 10 (10): 1–17. https://doi.org/10.3390/antibiotics10101146.
Djuikoue, Cecile Ingrid, Willy Yamdeu Djonkouh, Cavin Epie Bekolo, Rodrigue Kamga Wouambo, Raspail Carrel Founou, Paule Dana Djouela Djoulako, Gilder Tonfak Temgoua, Benjamin D.Thumamo Pokam, Nicolas Antoine-Moussiaux, and Teke R. Apalata. (2023). “Prevalence and Antibiotic Resistance Pattern of Streptococcus, Staphylococcus, Neisseria Meningitidis and Enterobacteriaceae in Two Reference Hospitals of Yaoundé: An Overview before and during COVID-19 Pandemic Era.” Antibiotics 12 (5). https://doi.org/10.3390/antibiotics12050929.
Golli, Andreea Loredana, Ovidiu Mircea Zlatian, Monica Laura Cara, and Mădălina Olteanu. (2024). “Pre- and Post-COVID-19 Antimicrobial Resistance Pattern of Pathogens in an Intensive Care Unit.” Pharmaceuticals 17 (4): 1–16. https://doi.org/10.3390/ph17040407.
HAMİDİ, Aziz Ahmad, and Şerife YILMAZ. (2021). “Antibiotic Consumption in the Hospital during COVID-19 Pandemic, Distribution of Bacterial Agents and Antimicrobial Resistance: A Single-Center Study.” Journal of Surgery and Medicine 5 (2): 124–27. https://doi.org/10.28982/josam.834535.
Hamisi, Nyaso Malilo, Baozhen Dai, and Masud Ibrahim. (2023). “Global Health Security amid COVID-19: Tanzanian Government’s Response to the COVID-19 Pandemic.” BMC Public Health 23 (1): 1–10. https://doi.org/10.1186/s12889-023-14991-7.
Katyali, Denis, Godfrey Kawau, Bjørn Blomberg, and Joel Manyahi. (2023). “Antibiotic Use at a Tertiary Hospital in Tanzania: Findings from a Point Prevalence Survey.” Antimicrobial Resistance and Infection Control 12 (1): 1–7. https://doi.org/10.1186/s13756-023-01317-w.
Khoshbakht, Reza, Mona Kabiri, Alireza Neshani, Mohammad Navid Khaksari, Sayyed Majid Sadrzadeh, Seyed Mohammad Mousavi, Kiarash Ghazvini, and Mahdis Ghavidel. (2022). “Assessment of Antibiotic Resistance Changes during the Covid-19 Pandemic in Northeast of Iran during 2020–2022: An Epidemiological Study.” Antimicrobial Resistance and Infection Control 11 (1): 1–11. https://doi.org/10.1186/s13756-022-01159-y.
Kishk, Rania M., Noha M.Abu Bakr, Maha Anani, Nader Nemr, Bassam M. Salama, Mohammed Samahy, Safaa M. Kishk, Naglaa E. Salem, and Hasnaa A. Mohamed. (2023). “Pattern of Antimicrobial Resistance in the Pre and during COVID-19 Era: An Observational Study.” Microbes and Infectious Diseases 4 (4): 1100–1113. https://doi.org/10.21608/MID.2023.217092.1539.
Kitaba, Abera A., Zelalem T. Bonger, Degefu Beyene, Zeleke Ayenew, Estifanos Tsige, Tesfa Addis Kefale, Yonas Mekonnen, Dejenie S. Teklu, Elias Seyoum, and Abebe A. Negeri. (2024). “Antimicrobial Resistance Trends in Clinical Escherichia Coli and Klebsiella Pneumoniae in Ethiopia.” African Journal of Laboratory Medicine 13 (1): 1–7. https://doi.org/10.4102/ajlm.v13i1.2268.
Kumburu, Happiness Houka, Tolbert Sonda, Blandina Theophil Mmbaga, Michael Alifrangis, Ole Lund, Gibson Kibiki, and Frank M. Aarestrup. (2017). “Patterns of Infections, Aetiological Agents and Antimicrobial Resistance at a Tertiary Care Hospital in Northern Tanzania.” Tropical Medicine and International Health 22 (4): 454–64. https://doi.org/10.1111/tmi.12836.
Lontsi Ngoula, Guy, Stéphanie Houcke, Séverine Matheus, Flaubert Nkontcho, Jean Marc Pujo, Nicolas Higel, Absettou Ba, et al. (2023). “Impact of Antibiotic Consumption on the Acquisition of Extended-Spectrum β-Lactamase Producing Enterobacterales Carriage during the COVID-19 Crisis in French Guiana.” Antibiotics 12 (1). https://doi.org/10.3390/antibiotics12010058.
Malik, Shahana Seher, and Sunil Mundra. (2023). “Increasing Consumption of Antibiotics during the COVID-19 Pandemic: Implications for Patient Health and Emerging Anti-Microbial Resistance.” Antibiotics 12 (1). https://doi.org/10.3390/antibiotics12010045.
Meena, Suneeta, Ginni Bharti, and Purva Mathur. (2023). “Pre- and Post-COVID-19 Appraisal of Antimicrobial Susceptibility for Urinary Tract Infections at an Outpatient Setting of a Tertiary Care Hospital in Delhi.” Cureus 15 (March 2021). https://doi.org/10.7759/cureus.47095.
Mirzaei, Bahman, Zahra Norouzi Bazgir, Hamid Reza Goli, Fatemeh Iranpour, Fatemeh Mohammadi, and Ryhaneh Babaei. (2020). “Prevalence of Multi-Drug Resistant (MDR) and Extensively Drug-Resistant (XDR) Phenotypes of Pseudomonas Aeruginosa and Acinetobacter Baumannii Isolated in Clinical Samples from Northeast of Iran.” BMC Research Notes 13 (1): 4–9. https://doi.org/10.1186/s13104-020-05224-w.
Murray, Christopher JL, Kevin Shunji Ikuta, Fablina Sharara, Lucien Swetschinski, Gisela Robles Aguilar, Authia Gray, Chieh Han, et al. (2022.) “Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis.” Lancet (London, England) 399 (10325): 629–55. https://doi.org/10.1016/S0140-6736(21)02724-0.
Muteeb, Ghazala, Md Tabish Rehman, Moayad Shahwan, and Mohammad Aatif.( 2023). “Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review.” Pharmaceuticals 16 (11): 1–54. https://doi.org/10.3390/ph16111615.
Namiganda, Victoria, Yousra Mina, Atika Meklat, Djamila Touati, Noureddine Bouras, Mustapha Barakate, and Nasserdine Sabaou. (2019). “Antibiotic Resistance Pattern of Acinetobacter Baumannii Strains Isolated from Different Clinical Specimens and Their Sensibility Against Bioactive Molecules Produced by Actinobacteria.” Arabian Journal for Science and Engineering 44 (7): 6267–75. https://doi.org/10.1007/s13369-019-03893-9.
Neema, Camara, Moremi Nyambura, Mghamba Janneth, Eliakimu Eliudi, Shumba Edwin, Ondoa Pascale, and Egyir Beverly. (2023). “Surveillance of Antimicrobial Resistance in Human Health in Tanzania: 2016-2021.” African Journal of Laboratory Medicine 12 (1): 1–8. https://doi.org/10.4102/ajlm.v12i1.2053.
OMS. 2024. WHO Bacterial Priority Pathogens List, (2024). Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance. https://www.who.int/publications/i/item/9789240093461.
Rizvi, Sidra Ghazali, and Shaikh Ziauddin Ahammad. (2022). “COVID-19 and Antimicrobial Resistance: A Cross-Study.” The Science of the Total Environment 807 (Pt 2): 150873. https://doi.org/10.1016/j.scitotenv.2021.150873.
Sageerabanoo, S., A. Malini, T. Mangaiyarkarasi, and G. Hemalatha. (2015). “Phenotypic Detection of Extended Spectrum β-Lactamase and Amp-C β-Lactamase Producing Clinical Isolates in a Tertiary Care Hospital: A Preliminary Study.” Journal of Natural Science, Biology and Medicine 6 (2): 383–87. https://doi.org/10.4103/0976-9668.160014.
Saini, Vikas, Charu Jain, Narendra Pal Singh, Ahmad Alsulimani, Chhavi Gupta, Sajad Ahmad Dar, Shafiul Haque, and Shukla Das. (2021). “Paradigm Shift in Antimicrobial Resistance Pattern of Bacterial Isolates during the Covid-19 Pandemic.” Antibiotics 10 (8): 1–11. https://doi.org/10.3390/antibiotics10080954.
Salihu, M.K, A Yarima, and H.I Atta. (2021). “Methods for the Phenotypic Detection of Extended Spectrum Beta Lactamase (ESBL)-Producing Bacteria.” Nigerian Journal of Biotechnology 37 (2): 113–25. https://doi.org/10.4314/njb.v37i2.11.
Sangeda, Raphael Z., Sahani M. William, Faustine C. Masatu, Adonis Bitegeko, Yonah H. Mwalwisi, Emmanuel A. Nkiligi, Pius G. Horumpende, and Adam M. Fimbo. (2024). “Antibiotic Utilization Patterns in Tanzania: A Retrospective Longitudinal Study Comparing Pre- and Intra-COVID-19 Pandemic Era Using Tanzania Medicines and Medical Devices Authority Data.” JAC-Antimicrobial Resistance 6 (3): 1–5. https://doi.org/10.1093/jacamr/dlae081.
Sartorius, Benn, Authia P Gray, Nicole Davis Weaver, Gisela Robles Aguilar, Lucien R Swetschinski, Kevin S Ikuta, Tomislav Mestrovic, et al. (2023). “The Burden of Bacterial Antimicrobial Resistance in the WHO African Region in 2019: A Cross-Country Systematic Analysis.” The Lancet Global Health, 201–16. https://doi.org/10.1016/s2214-109x(23)00539-9.
Shi, Ting, and Liangyi Xie. (2023). “Distribution and Antimicrobial Resistance Analysis of Gram-Negative Bacilli Isolated from a Tertiary Hospital in Central China: A 10-Year Retrospective Study from 2012 to 2021.” Frontiers in Microbiology 14 (December). https://doi.org/10.3389/fmicb.2023.1297528.
Sulayyim, Hadi Jaber Al, Rohani Ismail, Abdullah Al Hamid, and Noraini Abdul Ghafar. (2022). “Antibiotic Resistance during COVID-19: A Systematic Review.” International Journal of Environmental Research and Public Health 19 (19). https://doi.org/10.3390/ijerph191911931.
Taleb, Mohammed H., Abdelraouf A. Elmanama, Alaa H. Taleb, and Mahmoud M. Tawfick. (2023). “Pre- and Post-COVID-19 Antimicrobial Resistance Profile of Bacterial Pathogens, a Comparative Study in a Tertiary Hospital.” Journal of Infection in Developing Countries 17 (5): 597–609. https://doi.org/10.3855/jidc.17791.
Teferi, Sisay, Zewdineh Sahlemariam, Mekidim Mekonnen, Rahel Tamrat, Teshome Bekana, Yonas Adisu, and Tefera Darge. (2023). “Uropathogenic Bacterial Profile and Antibiotic Susceptibility Pattern of Isolates among Gynecological Cases Admitted to Jimma Medical Center, South West Ethiopia.” Scientific Reports 13 (1): 1–11. https://doi.org/10.1038/s41598-023-34048-4.
Thy, Michaël, Jean François Timsit, and Etienne de Montmollin. (2023). “Aminoglycosides for the Treatment of Severe Infection Due to Resistant Gram-Negative Pathogens.” Antibiotics 12 (5): 1–14. https://doi.org/10.3390/antibiotics12050860.
Tseng, Yu Wei, Chien Wen Huang, Chih Chieh Chen, and Tze Kiong Er. (2024). “Assessment of Antibiotic Resistance Patterns in Central Taiwan during the COVID-19 Pandemic: A Retrospective Study.” Journal of Infection and Public Health 17 (2): 229–35. https://doi.org/10.1016/j.jiph.2023.11.026.
URT-MoHCDGEC. (2021). “Standard Treatment Guidelines and National Essential Medicines List Tanzania Mainland.” Government of Tanzania 93 (3): 799–801. https://apps.who.int/medicinedocs/documents/s23541en/s23541en.pdf.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 African Journal of Infectious Diseases (AJID)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright: Creative Commons Attribution CC BY This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. View License Deed | View Legal Code Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications.
